Dr Mohta has been part of the Ariadne Labs community since 2013
Ariadne Labs has announced Namita Seth Mohta, as the new director of the Serious Illness Care Program, following a national search. As the director, Dr Mohta will lead the staff and faculty of the Serious Illness Care Program, establish programmatic vision and strategy, and sustain and expand the programme’s portfolio of research and innovations.THIS CAN BE YOUR ADVERTISEMENT
Dr Mohta has been part of the Ariadne Labs community since 2013. She formally joined the Serious Illness Care Program in 2019 as a faculty member where she has contributed to strategic planning, health system implementation, partnership development, programme measurement and evaluation, new solutions design and testing, and academic scholarship. During the COVID-19 pandemic, she helped develop the Serious Illness COVID-19 Response Toolkit, a multi-faceted planning and guidance resource, which has been accessed more than 13,000 times.
Trained in primary care, Dr Mohta has practised as an academic hospitalist at Brigham and Women’s Hospital since 2006, where a significant portion of her practice includes patients with serious illnesses. Throughout her clinical career, she has been committed to caring and advocating for patients with serious illnesses, including a focus on eliciting and honouring their values, goals, and priorities. She continues to train, teach, and mentor medical students and residents.
Dr Mohta is nationally known as a leader in healthcare delivery transformation. She serves as the Executive Editor for NEJM Catalyst, a peer-reviewed, academic journal published by the New England Journal of Medicine. NEJM Catalyst is focused on practical innovations in health care delivery. Dr Mohta is part of the founding leadership team that launched the platform. At NEJM Catalyst she has responsibility for editorial content strategy and quality.
Academically, she is Assistant Professor of Medicine at Harvard Medical School. She has served as faculty and senior advisor to the Center for Healthcare Delivery Sciences at Brigham and Women’s Hospital.
Dr Mohta said, “I am honoured to lead the Serious Illness Care Program and for the opportunity to bring my expertise as a clinician and leader to this critically important work. I am committed to building on the team’s success and furthering the team’s mission. We will continue to ask the right questions, pursue excellence in research and scholarship, build community, and develop and spread solutions that have an impact in the real world.”
She completed her Internal Medicine and Primary Care residency training at Brigham and Women’s Hospital. Dr Mohta is a graduate of Yale College and Yale School of Medicine.
